Antiparasitic Drugs Market
According to Intent Market Research, the Antiparasitic Drugs Market is expected to grow from USD 21.7 billion in 2023 at a CAGR of 5.9% to touch USD 32.5 billion by 2030. The Antiparasitic Drugs Market is dominated by key players such as Novartis AG, GlaxoSmithKline (GSK), Merck & Co., Sanofi S.A., Eli Lilly and Company, Bayer AG, Johnson & Johnson, Pfizer Inc., AbbVie Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., Amgen Inc., Boehringer Ingelheim, Mylan N.V., Takeda Pharmaceutical Company Limited